Fuller & Thaler Asset Management Inc. Purchases 128,163 Shares of Astera Labs, Inc. $ALAB

Key Points

• Fuller & Thaler Asset Management Inc. increased its stake in Astera Labs by 25.2%, acquiring an additional 128,163 shares, bringing their total ownership to approximately $37.98 million.
• Insiders sold approximately 2.18 million shares of Astera Labs stock in the last quarter, with significant sales by COO Sanjay Gajendra and Director Stefan A. Dyckerhoff.
• Astera Labs has shown strong growth, reporting a 149.5% increase in year-over-year revenue for the last quarter, with earnings surpassing analysts' expectations.

Fuller & Thaler Asset Management Inc. boosted its position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 25.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 636,536 shares of the company's stock after purchasing an additional 128,163 shares during the quarter. Fuller & Thaler Asset Management Inc. owned about 0.39% of Astera Labs worth $37,982,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Quantbot Technologies LP boosted its stake in Astera Labs by 372.8% in the 1st quarter. Quantbot Technologies LP now owns 146,551 shares of the company's stock valued at $8,745,000 after purchasing an additional 115,553 shares during the period. Wellington Management Group LLP boosted its stake in Astera Labs by 253.8% in the 1st quarter. Wellington Management Group LLP now owns 111,972 shares of the company's stock valued at $6,681,000 after purchasing an additional 80,327 shares during the period. American Century Companies Inc. boosted its stake in Astera Labs by 46.9% in the 1st quarter. American Century Companies Inc. now owns 6,783 shares of the company's stock valued at $405,000 after purchasing an additional 2,165 shares during the period. Liontrust Investment Partners LLP boosted its stake in Astera Labs by 100.3% in the 1st quarter. Liontrust Investment Partners LLP now owns 32,129 shares of the company's stock valued at $1,917,000 after purchasing an additional 16,092 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Astera Labs by 264.8% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 7,285 shares of the company's stock valued at $435,000 after purchasing an additional 5,288 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Astera Labs

In related news, COO Sanjay Gajendra sold 280,000 shares of the company's stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the completion of the sale, the chief operating officer directly owned 5,525,545 shares in the company, valued at $939,453,160.90. This represents a 4.82% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Stefan A. Dyckerhoff sold 25,000 shares of the company's stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $173.42, for a total value of $4,335,500.00. Following the sale, the director owned 99,154 shares of the company's stock, valued at approximately $17,195,286.68. This represents a 20.14% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 2,176,436 shares of company stock worth $259,714,061 over the last quarter. 12.50% of the stock is currently owned by company insiders.

Astera Labs Stock Down 8.2%

Shares of ALAB stock opened at $171.06 on Wednesday. Astera Labs, Inc. has a twelve month low of $36.85 and a twelve month high of $199.47. The company has a market cap of $28.43 billion, a P/E ratio of 305.46, a P/E/G ratio of 4.73 and a beta of 1.39. The business has a fifty day simple moving average of $118.96 and a 200 day simple moving average of $91.28.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. During the same period in the prior year, the company earned $0.13 EPS. Astera Labs's revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of recent analyst reports. Northland Capmk downgraded Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 22nd. William Blair initiated coverage on Astera Labs in a research report on Thursday, May 22nd. They set an "outperform" rating for the company. Needham & Company LLC upped their target price on Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Barclays reiterated an "overweight" rating and set a $155.00 target price (up from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. Finally, Roth Capital set a $100.00 target price on Astera Labs and gave the company a "buy" rating in a research report on Wednesday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, Astera Labs presently has an average rating of "Moderate Buy" and a consensus target price of $129.13.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.